AG
NVO

Ascent Group’s Novo Nordisk NVO Stock Holding History

Ascent Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Buy
8,855
+172
+2% +$7.39K 0.01% 572
2026
Q1 		$319K Buy
8,683
+453
+6% +$21.5K 0.01% 607
2025
Q4 		$419K Sell
8,230
-1,187
-13% -$60.7K 0.01% 532
2025
Q3 		$523K Sell
9,417
-6,253
-40% -$366K 0.02% 494
2025
Q2 		$1.08M Sell
15,670
-10,862
-41% -$739K 0.04% 318
2025
Q1 		$1.84M Buy
26,532
+6,218
+31% +$514K 0.08% 246
2024
Q4 		$1.75M Sell
20,314
-2,841
-12% -$307K 0.13% 193
2024
Q3 		$2.76M Buy
23,155
+286
+1% +$38.1K 0.21% 126
2024
Q2 		$3.26M Buy
22,869
+3,670
+19% +$486K 0.27% 94
2024
Q1 		$2.47M Buy
19,199
+795
+4% +$94.6K 0.22% 131
2023
Q4 		$2.22M Buy
18,404
+9,057
+97% +$896K 0.21% 134
2023
Q3 		$935K Sell
9,347
-715
-7% -$63K 0.1% 239
2023
Q2 		$952K Sell
10,062
-1,664
-14% -$136K 0.1% 242
2023
Q1 		$933K Buy
11,726
+532
+5% +$37.7K 0.1% 242
2022
Q4 		$757K Sell
11,194
-256
-2% -$15K 0.09% 249
2022
Q3 		$623K Sell
11,450
-1,566
-12% -$83.9K 0.08% 258
2022
Q2 		$755K Sell
13,016
-20
-0.2% -$1.11K 0.09% 243
2022
Q1 		$724K Buy
13,036
+4,648
+55% +$239K 0.08% 257
2021
Q4 		$400K Buy
+8,388
New +$454K 0.05% 334

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ascent Group's NVO Position: Q2 2026 in Review

Ascent Group increased its Novo Nordisk (NVO) stake by 2% in Q2 2026, buying an estimated $7.39K and bringing the position to 8,855 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #572.

Ascent Group first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.26M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Ascent Group held 8,855 shares of Novo Nordisk worth $424K as of Q2 2026.
  • Ascent Group bought 172 Novo Nordisk shares in Q2 2026, an estimated $7.39K.
  • Novo Nordisk made up 0.01% of Ascent Group's portfolio in Q2 2026, its #572 holding.
  • Ascent Group first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's Novo Nordisk position peaked at $3.26M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.